NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT00106002 2009-06-01Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerEli Lilly and CompanyPhase 2 Completed37 enrolled 9 charts